COMPLIANCE POLICY GUIDE (CPG)
Chapter 1 - General
Sub Chapter 110 - Exports/Imports
Sub Chapter 150 - Laboratory/Analytic
Sub Chapter 170 - Specific Problems Non-Food, Drug, or Cosmetic Related
Sub Chapter 100 - General
- CPG Sec.100.100 Responsibility for Reporting Possible or Potential Violations of Law Administered by FDA, Regulations Issued by FDA, Other Possible or Potential Hazards to the Public Health
- Compliance Policy Guide 100.200
- CPG Sec.100.250 Food Facility Registration- Human and Animal Food
- CPG Sec. 100.300 Non-FDA Regulated Products Involving Communicable Disease Hazards (CPG 7150.08) Page 3
- Compliance Policy Guide sec. 100.350
- Compliance Policy Guide sec 100.500
- CPG Sec. 100.550 Status and Responsibilities of Contract Sterilizers Engaged in the Sterilization of Drugs and Devices (CPG 7150.16)
- Compliance Policy Guide sec 100.600
- Compliance Policy Guide section 100.700
- Compliance Policy Guide Sec.100.950 International Partnership Agreements
- CPG Sec. 100.800 Guaranties Over Printed Signatures (CPG 7150.12) Page 7
- Compliance Policy Guide 7150.19
- CPG Sec. 101.100 FDA Considerations for Recommending Charges Under 21 U.S.C. §331(a) or (d) for Causing the Introduction of Violative Products into Interstate Commerce Guidance for FDA Staff
Sub Chapter 110 - Exports/Imports
- Compliance Policy Guide: Sec. 110.100 Certification for Exports (Compliance Policy Guide 7150.01)
- Compliance Policy Guide 7150.11
- Compliance Policy Guide, Guidance for FDA and CBP Staff: Prior Notice of Imported Food
- Compliance Policy Guide 7153.10
- Compliance Policy Guide Sec. 110.600
- Compliance Policy Guide Sec. 110.700
- Compliance Policy Guide Sec. 110.800
- Compliance Policy Guide Sec. 110.900
Sub Chapter 120 - Fraud
- Compliance Policy Guide Section 120-100 (7150.09) Compliance Policy Guide: Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities
- Compliance Policy Guide Sec. 120.500
Sub Chapter 130 - Inspections
- Compliance Policy Guide Sec. 130.100
- Compliance Policy Guide Sec. 130.200
- Compliance Policy Guide Sec. 130.300
- Compliance Policy Guide Sec. 130.400 Microfiche and/or Microfilm for Method of Records Retention
Sub Chapter 140 - Labeling
Sub Chapter 150 - Laboratory/Analytics
- Compliance Policy Guide 7150.18
- Compliance Policy Guide Sec. 150.200 Compliance Review of Private Laboratory Analytical Packages (PLAPs)
- Compliance Policy Guide 7152.01
Sub Chapter 160 - Regulatory
- Compliance Policy Guide 7153.12
- Compliance Policy Guide 7153.09
- Compliance Policy Guide 7153.02
- Compliance Policy Guide 7153.03
- Compliance Policy Guide 7153.05
- Compliance Policy Guide 7153.07
- Compliance Policy Guide 7153.04
- Compliance Policy Guide 7153.14
- Compliance Policy Guide 160-800, Year 2000 (Y2K) Computer Compliance (Compliance Policy Guide 7153.15)
- Compliance Policy Guide Sec. 160.850: Enforcement Policy: 21 CFR Part 11; Electronic Records; Electronic Signatures (Compliance Policy Guide 7153.17)
- Compliance Policy Guide Sec. 160-900: Prescription Drug Marketing Act -- Pedigree Requirements under 21 CFR Part 203
Chapter 170 - Specific Problems - Non-Food, Drug, or Cosmetic Related
Submit Comments
Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All comments should be identified with the title of the guidance.